Literature DB >> 21368620

The prevalence and current opinion of treatment of allergic rhinitis in elite athletes.

Hendrik P Dijkstra1, Paula Robson-Ansley.   

Abstract

PURPOSE: The aim of this review is to highlight the prevalence of allergic rhinitis in athletes and the impact this condition may have on their athletic performance. Furthermore, the optimal management of medical conditions in the elite athlete forms an important part of protecting the health of the athlete. RECENT
FINDINGS: The use of pharmacological intervention in the treatment of allergic rhinitis in elite athletes requires careful planning. A variety of factors must be considered prior to prescription such as drug efficacy and safety both at rest and in conjunction with strenuous exercise, associated side effects on athletic performance and well being and whether the chosen drug is on the World Anti-Doping Agency (WADA) banned list.
SUMMARY: Allergic rhinitis is common in elite athletes and may impair athletic performance and recovery. We advise that all elite and professional athletes should be screened for allergic rhinitis using validated questionnaire such as the Allergy Questionnaire for Athletes (AQUA) alongside skin prick testing or specific IgE blood tests for inhalant allergens. Intranasal corticosteroids are highly recommended as the management drug of choice for athletes in conjunction with second-generation antihistamines (severity dependant) and when practicable, allergen avoidance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21368620     DOI: 10.1097/ACI.0b013e3283445852

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  6 in total

Review 1.  Tryptophan Metabolism in Allergic Disorders.

Authors:  Johanna M Gostner; Katrin Becker; Heinz Kofler; Barbara Strasser; Dietmar Fuchs
Journal:  Int Arch Allergy Immunol       Date:  2016-05-04       Impact factor: 2.749

2.  Upper Respiratory Tract Diseases in Athletes in Different Sports Disciplines.

Authors:  Anna Gałązka-Franta; Edyta Jura-Szołtys; Wojciech Smółka; Radosław Gawlik
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

Review 3.  Old Friends, immunoregulation, and stress resilience.

Authors:  Dominik Langgartner; Christopher A Lowry; Stefan O Reber
Journal:  Pflugers Arch       Date:  2018-11-01       Impact factor: 3.657

4.  Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Authors:  Mustafa Cenk Ecevit; Müge Özcan; İlknur Haberal Can; Emel Çadallı Tatar; Serdar Özer; Erkan Esen; Doğan Atan; Sercan Göde; Çağdaş Elsürer; Aylin Eryılmaz; Berna Uslu Coşkun; Zahide Mine Yazıcı; Mehmet Emre Dinç; Fatih Özdoğan; Kıvanç Günhan; Nagihan Bilal; Arzu Yasemin Korkut; Fikret Kasapoğlu; Bilge Türk; Ela Araz Server; Özlem Önerci Çelebi; Tuğçe Şimşek; Rauf Oğuzhan Kum; Mustafa Kemal Adalı; Erdem Eren; Nesibe Gül Yüksel Aslıer; Tuba Bayındır; Aslı Çakır Çetin; Ayşe Enise Göker; Işıl Adadan Güvenç; Sabri Köseoğlu; Gül Soylu Özler; Ethem Şahin; Aslı Şahin Yılmaz; Ceren Güne; Gökçe Aksoy Yıldırım; Bülent Öca; Mehmet Durmuşoğlu; Yunus Kantekin; Süay Özmen; Gözde Orhan Kubat; Serap Köybaşı Şanal; Emine Elif Altuntaş; Adin Selçuk; Haşmet Yazıcı; Deniz Baklacı; Atılay Yaylacı; Deniz Hancı; Sedat Doğan; Vural Fidan; Kemal Uygur; Nesil Keleş; Cemal Cingi; Bülent Topuz; Salih Çanakçıoğlu; Metin Önerci
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-05

5.  AQUA© as predictor of allergy in elite marathon runners.

Authors:  Renata N Teixeira; Felipe Ar Mendes; Milton A Martins; Timothy D Mickleborough; Celso Rf Carvalho
Journal:  World Allergy Organ J       Date:  2014-04-03       Impact factor: 4.084

6.  Managing the health of the elite athlete: a new integrated performance health management and coaching model.

Authors:  H Paul Dijkstra; N Pollock; R Chakraverty; J M Alonso
Journal:  Br J Sports Med       Date:  2014-04       Impact factor: 13.800

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.